US regulators to weigh controversial peptides backed by RFK Jr
FDA has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-aging.Published On 22 Jul 202622 Jul 2026Peptides, a class of compounds increasingly marketed…
California makes controversial change to…
At Friday’s meeting, board members grilled CARB staff for hours over this risk. Rajinder Sahota, CARB’s deputy executive officer for climate change and research, asserted that analyses from environmental advocates…